Friday
Jun032011
Canadian Glaucoma Study update (Dr Fred Mikelberg)
Dr Mikelberg started by reviewing some of the prior data and also some of the data recently shown at ARVO and that was still in press at the time this talk was given.
Welcome to the Canadian Ophthalmological Society Annual Meeting unofficial blog of topics of interest to glaucoma specialists like myself. This conference is being held in Quebec City from June 26-29, 2010 and therefore you will see many changes to this section of the blog as I update my entries each day. I would like to encourage readers to add their comments to these postings as they appear.
June 26-29, 2010
Highlights of presentations of particular interest to glaucoma specialists
27May2011 Note: I am continuing to edit these articles and ‘publishing’ new entries as I complete each one. WIth the 74th Annual COS Meeting June 9-12, 2011 from Vancouver, I will be sure to finish editing last year’s articles and get ready for the new conference blog.
Entries in Epidemiology (4)
Friday
Oct082010
Disease severity at diagnosis of OAG in Canada (Dr Yvonne Buys)
26Jun2010 1130hrs presented at the COS Annual Meeting in Quebec City by Dr Yvonne Buys. In this presentation, Dr Buys talks about the disease severity of open angle glaucoma at diagnosis time. Despite being a treatable condition, glaucoma is still a leading cause of blindness in Canada.
tagged 
Canada, Epidemiology, OAG, prevalence |
Canada, Epidemiology, OAG, prevalence | Tuesday
Aug102010
Epidemiology of angle closure glaucoma (Mr Paul Foster, MB, PhD, FRCS)
26Jun2010 1100hrs presented at the COS Annual Meeting in Quebec City by Mr Paul Foster from Moorfields Eye Hospital. Mr Foster begins by reviewing the same 2010 and 2020 prevalence data and the current classification system and makes interesting points about how angle closure glaucoma can be more damaging than open angle glaucoma.
Monday
Aug022010
Epidemiology of Glaucoma in Canada, fact or fiction (Dr Delan Jinapriya)
Dr Jinapriya starts his talk with some basics defining prevalence (total numbers in population) and incidence (new cases.) He points out that there are lots of prevalence studies from around the world but asks if we can extrapolate and apply to the Canadian population.